CIK 0001711754
- Non-accelerated filer
- Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 475205835
- Phone
- +1 858-964-3720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- 4/A Other acquisition 10% owner acquired 192,533 shares (other)
- 4 Option exercise 10% owner acquired 108,000 shares (option exercise)
- 4/A Other acquisition 10% owner acquired 192,533 shares (other)
- 4 Option exercise President and CEO acquired 30,000 shares (option exercise)
- 4 Option exercise CFO, Treasurer & Secretary acquired 25,000 shares (option exercise)
- 4 Open-market sale Director sold 14,480 shares at $27.63 ($400,082)
- 4 Open-market sale Director sold 30,000 shares at $23.21 ($696,150)
- 4 Open-market sale Chief Scientific Officer sold 30,000 shares at an average $20.16 ($604,706)
- 4 Open-market sale CFO, Treasurer & Secretary sold 25,000 shares at an average $20.06 ($501,523)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $20.07 ($602,050)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $19.02 ($190,200)
- 4 Other acquisition 10% owner acquired 192,532 shares (other)
- 4 Open-market sale Director sold 10,000 shares at $17.01 ($170,054)
Page 5 of 8 · 142 filings